2006 Annual Meeting | Acute Stroke Management

Date Saturday 04/01/06

Time 06:00 PM - 08:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Kick-Off Program

Director(s) Lawrence R. Wechsler, MD, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should become familiar with the diagnostic approach to the patient with acute stroke; understand the data supporting various acute stroke therapies including medical management, thrombolytics, neuroprotectants, and interventional treatments; and learn how new approaches, such as imaging, can improve acute stroke care by improving patient selection.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident, Nurse

Event Timeline
06:00 PM - 06:20 PM		Medical Management of Acute Stroke Lawrence R. Wechsler, MD, FAAN
06:00 PM - 08:00 PM		Reception
06:20 PM - 06:40 PM		Thrombolytic Therapy for Acute Stroke Joseph P. Broderick, MD, FAAN
06:40 PM - 07:00 PM		MERCI and Other Devices Tudor G. Jovin, MD
07:00 PM - 07:20 PM		Whom Do We Treat? Patient Selection Walter J. Koroshetz, MD, FAAN
07:20 PM - 07:40 PM		Billing and Coding for Acute Stroke Marc R. Nuwer, MD, PhD, FAAN
07:40 PM - 08:00 PM		Case Discussions

Faculty Disclosures
Joseph P. Broderick, MD, FAAN	Dr. Broderick has received publishing royalties from a publication relating to health care.
Walter J. Koroshetz, MD, FAAN	Dr. Koroshetz has nothing to disclose.
Marc R. Nuwer, MD, PhD, FAAN	Dr. Nuwer has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Corticare. Dr. Nuwer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Nuwer has received research support from Second Sight. Dr. Nuwer has received publishing royalties from a publication relating to health care.
Lawrence R. Wechsler, MD, FAAN	Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Wechsler has stock in Forest Devices.
Tudor G. Jovin, MD	Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Contego Medical. Dr. Jovin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Jovin has stock in Corindus. Dr. Jovin has stock in Methinks. Dr. Jovin has stock in Viz.ai. Dr. Jovin has stock in Route92. Dr. Jovin has stock in FreeOx Biotech. Dr. Jovin has stock in Galaxy. Dr. Jovin has stock in Kandu. The institution of Dr. Jovin has received research support from Stryker. The institution of Dr. Jovin has received research support from Medtronic.

��ɫ��

��ɫ��